134 related articles for article (PubMed ID: 34596738)
21. [Short-term outcomes and prognosis of palliative surgery for malignant bowel obstruction caused by peritoneal metastasis of colorectal cancer].
Chen PJ; Wang L; Chen N; Lu XY; Wang HS; He X; Wang Z; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Nov; 22(11):1051-1057. PubMed ID: 31770836
[No Abstract] [Full Text] [Related]
22. Incidence of and survival after surgical intervention for bowel obstruction in women with advanced ovarian cancer.
Pálsdóttir K; Salehi S; Johansson H; Groes-Kofoed N; Falconer H; Joneborg U
Acta Obstet Gynecol Scand; 2023 Dec; 102(12):1653-1660. PubMed ID: 37681645
[TBL] [Abstract][Full Text] [Related]
23. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
[TBL] [Abstract][Full Text] [Related]
24. Intestinal surgery in treatment of advanced ovarian cancer--review of our experience.
Stefanović A; Jeremić K; Kadija S; Milincić N; Mircić A; Petković S; Zizić V
Eur J Gynaecol Oncol; 2011; 32(4):419-22. PubMed ID: 21941966
[TBL] [Abstract][Full Text] [Related]
25. Possible role of palliative surgery for bowel obstruction in advanced ovarian cancer patients.
Sartori E; Chiudinelli F; Pasinetti B; Sostegni B; Maggino T
Eur J Gynaecol Oncol; 2010; 31(1):31-6. PubMed ID: 20349778
[TBL] [Abstract][Full Text] [Related]
26. Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study.
Eisenkop SM; Friedman RL; Wang HJ
Cancer; 1995 Nov; 76(9):1606-14. PubMed ID: 8635065
[TBL] [Abstract][Full Text] [Related]
27. Bowel surgery for epithelial ovarian cancer--an early case series.
Chia YN; Tay EH; Cheong DM; Eu KW; Low J; Ho TH; Yam KL
Ann Acad Med Singap; 2003 Sep; 32(5):661-4. PubMed ID: 14626798
[TBL] [Abstract][Full Text] [Related]
28. Extent and distribution of peritoneal disease in patients undergoing cytoreductive surgery for first platinum sensitive recurrence in ovarian cancer and its potential therapeutic implications.
Bhatt A; Bakrin N; Gertych W; Kammar P; Parikh L; Sheth S; Shaikh S; Devouassoux-Shisheboran M; Glehen O
Eur J Surg Oncol; 2020 Dec; 46(12):2276-2282. PubMed ID: 32600895
[TBL] [Abstract][Full Text] [Related]
29. Benefit of palliative surgery for bowel obstruction in advanced ovarian cancer.
Jong P; Sturgeon J; Jamieson CG
Can J Surg; 1995 Oct; 38(5):454-7. PubMed ID: 7553472
[TBL] [Abstract][Full Text] [Related]
30. Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome.
Bristow RE; Peiretti M; Gerardi M; Zanagnolo V; Ueda S; Diaz-Montes T; Giuntoli RL; Maggioni A
Gynecol Oncol; 2009 Aug; 114(2):173-7. PubMed ID: 19482344
[TBL] [Abstract][Full Text] [Related]
31. Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis.
Mangili G; Aletti G; Frigerio L; Franchi M; Panacci N; Viganò R; DE Marzi P; Zanetto F; Ferrari A
Int J Gynecol Cancer; 2005; 15(5):830-5. PubMed ID: 16174232
[TBL] [Abstract][Full Text] [Related]
32. Extraperitoneal en bloc intestinal resection as palliative surgery for treatment refractory bowel obstruction in ovarian cancer relapse.
Fotopoulou C; Haidopoulos D
Int J Gynecol Cancer; 2020 May; 30(5):711. PubMed ID: 31992600
[No Abstract] [Full Text] [Related]
33. Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma.
Gockley AA; Fiascone S; Hicks Courant K; Pepin K; Del Carmen M; Clark RM; Goldberg J; Horowitz N; Berkowitz R; Worley M
Int J Gynecol Cancer; 2019 Mar; 29(3):585-592. PubMed ID: 30833444
[TBL] [Abstract][Full Text] [Related]
34. Avoiding bevacizumab related gastrointestinal toxicity for recurrent ovarian cancer by careful patient screening.
Simpkins F; Belinson JL; Rose PG
Gynecol Oncol; 2007 Oct; 107(1):118-23. PubMed ID: 17658587
[TBL] [Abstract][Full Text] [Related]
35. Outcomes and patterns of secondary relapse in platinum-sensitive ovarian cancer: implications for tertiary cytoreductive surgery.
Tang J; Liu DL; Shu S; Tian WJ; Liu Y; Zang RY
Eur J Surg Oncol; 2013 Jul; 39(7):786-91. PubMed ID: 23490332
[TBL] [Abstract][Full Text] [Related]
36. Maximal effort cytoreductive surgery for disseminated ovarian cancer in a UK setting: challenges and possibilities.
Fotopoulou C; Jones BP; Savvatis K; Campbell J; Kyrgiou M; Farthing A; Brett S; Roux R; Hall M; Rustin G; Gabra H; Jiao L; Stümpfle R
Arch Gynecol Obstet; 2016 Sep; 294(3):607-14. PubMed ID: 27040418
[TBL] [Abstract][Full Text] [Related]
37. Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy.
Matsumoto A; Higuchi T; Yura S; Mandai M; Kariya M; Takakura K; Fujii S
J Obstet Gynaecol Res; 2006 Dec; 32(6):580-7. PubMed ID: 17100820
[TBL] [Abstract][Full Text] [Related]
38. The use of colorectal stents for palliation of large-bowel obstruction due to recurrent gynecologic cancer.
Pothuri B; Guirguis A; Gerdes H; Barakat RR; Chi DS
Gynecol Oncol; 2004 Dec; 95(3):513-7. PubMed ID: 15581955
[TBL] [Abstract][Full Text] [Related]
39. Malignant bowel obstruction due to uterine or ovarian cancer: Are there differences in outcome?
Hoppenot C; Peters P; Cowan M; Moore ED; Hurteau J; Lee NK; Yamada SD
Gynecol Oncol; 2019 Jul; 154(1):177-182. PubMed ID: 31056111
[TBL] [Abstract][Full Text] [Related]
40. The Prognostic Role of Optimal Cytoreduction in Advanced, Bowel Infiltrating Ovarian Cancer.
Bachmann R; Rothmund R; Krämer B; Brucker SY; Königsrainer A; Königsrainer I; Beckert S; Staebler A; NguyenHuu P; Grischke E; Wallwiener D; Bachmann C
J Invest Surg; 2015 Jun; 28(3):160-6. PubMed ID: 25565126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
